GlobeNewsWire · MDGL · November 13, 2026

Kaplan Fox is Investigating Claims on Behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Investors for Potential Securities Law Violations

Get the app for more

Explore stock news, insights and company research.